This introductory and comprehensive online certificate program will explore diabetes technology, including continuous glucose monitoring (CGM), remote glucose monitoring, insulin pumps, and connected insulin pens. Participants will learn best practices for utilizing these technologies and the data generated by each to monitor glucose levels, administer insulin, conduct successful patient visits, and make informed decisions to manage and improve patient outcomes with diabetes.

Physician Credit

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 6 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

Provider approved by the California Board of Registered Nursing, Provider Number 17762, for 6 contact hours.

By the end of the activity, participants will be able to:

• Recognize the evolution and impact of diabetes technology on treating and managing diabetes.
• Evaluate patients based on their glycemic trends, lifestyle, and preferences to determine and recommend the most optimal diabetes technology.
• Explain the different types of continuous glucose monitors, their functions, and the benefits and limitations of continuous glucose monitors (CGM) for diabetes management.
• Interpret CGM data using the Ambulatory Glucose Profile (AGP) report to inform decision-making about diabetes treatment and management strategies.
• Discover the difference between real-time and on-demand glucose monitoring.
• Compare and contrast technology software platforms and clinical staff methods for conducting telemonitoring.
• Recognize how advanced diabetes technologies like the smart pen and insulin pump administer insulin.
• Calculate patient insulin dosages for use in insulin pumps and smart pens.

The primary target audience includes Nurse Practitioners, Physician Assistants, and Pharmacists. The secondary target audience includes Endocrinologists, and Primary Care Physicians.